Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24297724)

1.

Percutaneous patent foramen ovale closure in a patient with inferior vena cava filter.

Sabiniewicz R, Meyer-Szary J, Potaż P, Jaguszewski M.

Kardiol Pol. 2013;71(11):1207. doi: 10.5603/KP.2013.0307. No abstract available.

2.

Transhepatic approach to closure of patent foramen ovale: report of 2 cases in adults.

Hussain J, Strumpf R, Ghandforoush A, Jamal A, Diethrich E.

Tex Heart Inst J. 2010;37(5):553-6.

3.

Percutaneous closure of patent foramen ovale in cryptogenic embolism.

Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P; PC Trial Investigators.

N Engl J Med. 2013 Mar 21;368(12):1083-91. doi: 10.1056/NEJMoa1211716.

4.

Treatment of recurrent stroke and pulmonary thromboembolism with percutaneous closure of a patent foramen ovale and placement of inferior vena cava filter.

Donti A, Giardini A, Formigari R, Bronzetti G, Prandstraller D, Bonvicini M, Picchio FM.

Catheter Cardiovasc Interv. 2003 Mar;58(3):413-5.

PMID:
12594715
5.

[Patent foramen ovale can cause cryptogenic stroke. Transcatheter closure as an alternative to medical therapy must be evaluated more].

Ladenvall P, Dellborg M.

Lakartidningen. 2013 Sep 4-10;110(36):1524-5. Swedish. No abstract available.

PMID:
24163903
6.
7.

Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.

Li Y, Zhou K, Hua Y, Wang C, Xie L, Fang J, Rong X, Shen J.

Cardiol Young. 2013 Aug;23(4):582-96. doi: 10.1017/S1047951112001424. Epub 2012 Dec 3.

PMID:
23199453
8.

[Patent foramen ovale: a harmless fetal remnant that can be a threat in adulthood].

Eriksson PJ, Jacobsen P.

Lakartidningen. 2011 May 18-24;108(20):1123-5. Review. Swedish. No abstract available.

PMID:
21815346
9.

Percutaneous device closure of patent foramen ovale for cryptogenic strokes/transient ischemic attacks.

Freund MA, Reeder GS, Cabalka AK, Cetta F, Hagler DJ.

JACC Cardiovasc Interv. 2012 Nov;5(11):1189; author reply 1189. doi: 10.1016/j.jcin.2012.08.009. No abstract available.

10.

Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.

Bonvini RF, Sztajzel R, Dorsaz PA, Righini M, Bonvin C, Alibegovic J, Sigwart U, Camenzind E, Verin V, Sztajzel J.

Int J Stroke. 2010 Feb;5(1):4-9. doi: 10.1111/j.1747-4949.2009.00336.x.

PMID:
20088986
12.

Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.

Luna M, Banerjee S, Brilakis ES.

Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):63-6. doi: 10.1016/j.carrev.2008.09.004.

PMID:
20129363
13.

Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.

Sorensen SG, Aguilar H, McKnight WK, Thomas H, Muhlestein JB.

J Interv Cardiol. 2010 Dec;23(6):575-80. doi: 10.1111/j.1540-8183.2010.00587.x. Epub 2010 Aug 27.

PMID:
20796165
14.

Occlusion of PFO with a dedicated adjustable device: influence on one year outcome.

Kleber FX, Winkelmann A, Stretz A, Sonntag SM, Bruch L, Rademacher G, Sparenberg P, Schmehl I.

EuroIntervention. 2010 Aug;6(3):367-70. doi: 10.4244/EIJV6I3A61.

PMID:
20884416
15.

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.

16.

[Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].

Mazuelos F, Suárez de Lezo J, Pan M, Mesa D, Delgado M, Ruiz M, Ojeda S, Esteban F.

Rev Esp Cardiol. 2008 Jun;61(6):640-3. Spanish.

17.

Congenital heart conditions: Patent foramen ovale closure--not all devices are equal.

Meier B.

Nat Rev Cardiol. 2013 Oct;10(10):558-9. doi: 10.1038/nrcardio.2013.136. Epub 2013 Sep 3. No abstract available.

PMID:
23999180
18.

Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.

Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B.

Circulation. 2012 Feb 14;125(6):803-12. doi: 10.1161/CIRCULATIONAHA.111.030494. Epub 2012 Jan 11.

19.

Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.

Korabathina R, Thaler DE, Kimmelstiel C.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):498-502. doi: 10.1002/ccd.23342. Epub 2011 Oct 13.

PMID:
21953702
20.

PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registry.

Wöhrle J, Bertrand B, Søndergaard L, Turner M, Scholtz W, Ibrahim R, Bourlon F.

Clin Res Cardiol. 2012 Oct;101(10):787-93. Epub 2012 Apr 10.

PMID:
22487724
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk